A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics.
BACKGROUND
The incidence of cutaneous squamous cell carcinoma (cSCC) is increasing. Although most patients achieve complete remission with surgical treatment, those with advanced disease have a poor prognosis. The American Joint Committee on Cancer (AJCC) is responsible for the staging criteria for all cancers. For the past 20 years, the AJCC cancer staging manual has grouped all nonmelanoma skin cancers, including cSCC, together for the purposes of staging. However, based on new evidence, the AJCC has determined that cSCC should have a separate staging system in the 7th edition AJCC staging manual.


OBJECTIVE
We sought to present the rationale for and characteristics of the new AJCC staging system specific to cSCC tumor characteristics (T).


METHODS
The Nonmelanoma Skin Cancer Task Force of AJCC reviewed relevant data and reached expert consensus in creating the 7th edition AJCC staging system for cSCC. Emphasis was placed on prospectively accumulated data and multivariate analyses. Concordance with head and neck cancer staging system was also achieved.


RESULTS
A new AJCC cSCC T classification is presented. The T classification is determined by tumor diameter, invasion into cranial bone, and high-risk features, including anatomic location, tumor thickness and level, differentiation, and perineural invasion.


CONCLUSIONS
The data available for analysis are still suboptimal, with limited prospective outcomes trials and few multivariate analyses.


CONCLUSIONS
The new AJCC staging system for cSCC incorporates tumor-specific (T) staging features and will encourage coordinated, consistent collection of data that will be the basis of improved prognostic systems in the future.
School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Sharifeh
S
Farasat
Siegrid S
SS
Yu
Victor A
VA
Neel
Kishwer S
KS
Nehal
Thomas
T
Lardaro
Martin C
MC
Mihm
David R
DR
Byrd
Charles M
CM
Balch
Joseph A
JA
Califano
Alice Y
AY
Chuang
William H
WH
Sharfman
Jatin P
JP
Shah
Paul
P
Nghiem
Clark C
CC
Otley
Anthony P
AP
Tufaro
Timothy M
TM
Johnson
Arthur J
AJ
Sober
Nanette J
NJ
Liégeois
D002294:Carcinoma, Squamous Cell / Q000145:classification / Q000473:pathology*; D002454:Cell Differentiation; D006801:Humans; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging / Q000145:classification*; D011379:Prognosis; D012878:Skin Neoplasms / Q000145:classification / Q000473:pathology*
Cancer. 1997 Mar 1;79(5):920-3
9041154
Dermatol Surg. 2002 Mar;28(3):268-73
11896781
Pathol Res Pract. 1998;194(5):319-24
9651944
Oral Oncol. 2004 Jan;40(1):92-8
14662421
J Am Acad Dermatol. 1994 Jul;31(1):30-3
8021368
Arch Dermatol. 2003 Mar;139(3):301-6
12622621
Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2006-11
15598755
Arch Dermatol. 1990 Feb;126(2):185-8
2301956
Arch Otolaryngol Head Neck Surg. 1998 Jun;124(6):637-40
9639472
J Clin Oncol. 2005 Feb 1;23(4):759-65
15681519
J Dermatol Surg Oncol. 1978 Jan;4(1):41-54
618934
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
17237035
Head Neck. 2007 Jun;29(6):525-7
17427972
J Am Acad Dermatol. 1992 Jun;26(6):976-90
1607418
Laryngoscope. 2003 Oct;113(10):1827-33
14520114
Br J Dermatol. 2000 Dec;143(6):1224-9
11122025
Cancer. 1997 Mar 1;79(5):915-9
9041153
Dermatology. 1994;189(1):52-4
8003787
J Am Acad Dermatol. 2005 Aug;53(2):261-6
16021121
Laryngoscope. 2005 Sep;115(9):1561-7
16148695
Dermatol Surg. 2005 Nov;31(11 Pt 1):1379-84
16416604
Cancer. 1985 Sep 1;56(5):1099-105
4016700
Lancet Oncol. 2008 Aug;9(8):713-20
18617440
J Am Acad Dermatol. 1989 Aug;21(2 Pt 1):241-8
2768574
J Plast Reconstr Aesthet Surg. 2006;59(12):1288-93
17113505
Surg Clin North Am. 1994 Oct;74(5):1247-57
7940072
Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):103-6
17413411
N Engl J Med. 2001 Mar 29;344(13):975-83
11274625
J Cutan Pathol. 2002 Jul;29(6):321-3
12135462
Cancer. 2006 Jun 1;106(11):2389-96
16649220
Head Neck. 2004 Aug;26(8):727-32
15287040
Head Neck. 2007 Jul;29(7):621-31
17230560
J Surg Oncol. 1996 Feb;61(2):124-30
8606543
J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):177-86
10025742
Lancet. 1989 Jan 21;1(8630):124-9
2563048
Int J Cancer. 1998 Nov 23;78(5):587-93
9808527
J Biomed Biotechnol. 2007;2007(3):80572
17541471
Am J Surg. 1984 Oct;148(4):542-7
6486325
Br J Dermatol. 2002 Apr;146 Suppl 61:1-6
11966724
Ann Surg Oncol. 2006 Jul;13(7):902-9
16788750
Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):750-3
12874077
Cancer. 2006 Mar 1;106(5):1078-83
16444748
Arch Otolaryngol Head Neck Surg. 1998 May;124(5):582-7
9604987
Head Neck. 2002 May;24(5):417-22
12001070
Head Neck. 2002 Apr;24(4):319-25
11933172
Cancer. 1950 Jul;3(4):657-66
15427069
Cancer. 1999 Apr 15;85(8):1758-64
10223570
N Engl J Med. 2003 Apr 24;348(17):1681-91
12711744
Am J Clin Pathol. 1990 Nov;94(5):624-7
2239827
Dermatol Surg. 2007 Aug;33(8):885-99
17661931
Histopathology. 2006 Sep;49(3):256-64
16918972
Dermatol Surg. 2001 Jun;27(6):531-42
11442588
Ann Surg. 1921 Feb;73(2):141-60
17864409
Head Neck. 2003 Dec;25(12):1027-33
14648861